Emvizid 0.3 Tablet SR
Prescription Required
Introduction of Emvizid Tablet SR
Emvizid 0.3 Tablet SR belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Emvizid 0.3 Tablet SR is used in the treatment of type 2 diabetes. It is a combination of two medicines that effectively control blood sugar levels, when a single medication is not effective. It should be used along with proper diet and regular exercise for best results. Monitor your blood sugar level regularly while you are taking this medicine as it may cause hypoglycemia (low blood sugar level).
Emvizid 0.3 Tablet SR is used in the treatment of type 2 diabetes. It is a combination of two medicines that effectively control blood sugar levels, when a single medication is not effective. It should be used along with proper diet and regular exercise for best results. Monitor your blood sugar level regularly while you are taking this medicine as it may cause hypoglycemia (low blood sugar level).
Uses of Emvizid Tablet SR
Benefits of Emvizid Tablet SR
In Treatment of Type 2 diabetes mellitus
Emvizid 0.3 Tablet SR is a medicine that helps to control high blood glucose (sugar) levels. It helps to slow down the breaking down of food in our intestine to simple glucose (sugar), thereby decreasing the rise in blood glucose levels after meals. It also helps get rid of extra glucose from your body through urine. Lowering blood glucose levels is an essential part of managing diabetes. If you can control the level, you will reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs.
Emvizid 0.3 Tablet SR will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Emvizid 0.3 Tablet SR will reduce the risk of dying from cardiovascular disease if you have type 2 diabetes and already have cardiovascular disease. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using it for as long as it is prescribed because it is protecting your future health.
Side effects of Emvizid Tablet SR
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youβre worried about them
Common side effects of Emvizid
- Hypoglycemia (low blood glucose level)
- Nausea
- Taste change
- Diarrhea
- Stomach pain
- Flatulence
- Headache
- Skin rash
- Respiratory tract infection
How to use Emvizid Tablet SR
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Emvizid 0.3 Tablet SR is to be taken with food.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Emvizid 0.3 Tablet SR.
Pregnancy
CONSULT YOUR DOCTOR
Emvizid 0.3 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Emvizid 0.3 Tablet SR is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
CAUTION
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Kidney
CAUTION
Emvizid 0.3 Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Emvizid 0.3 Tablet SR may be needed. Please consult your doctor.
Use of Emvizid 0.3 Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Use of Emvizid 0.3 Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Liver
CAUTION
Emvizid 0.3 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Emvizid 0.3 Tablet SR may be needed. Please consult your doctor.
Emvizid 0.3 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Emvizid 0.3 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Emvizid 0.3 Tablet SR
βΉ19.9/Tablet SR
Vogli Trio 0.3 Tablet SR
Medley Pharmaceuticals
βΉ17.1/tablet sr
7% cheaper
Glizest MV 0.3mg/500mg/80mg Tablet SR
Trumac Healthcare
βΉ16.13/tablet sr
12% cheaper
Rest M Trio 0.3mg/500mg/80mg Tablet SR
Cosmic Life Sciences
βΉ15.7/tablet sr
14% cheaper
Quick tips
Emvizid Tablet SR
- Take it with food to lower your chance of having an upset stomach.
- It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief.
- Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Fact Box
Habit Forming
No
Therapeutic Class
ANTI DIABETIC
Patient concerns
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7. [Accessed 08 Apr. 2019] (online) Available from:
- Metformin hydrochloride oral solution. Gloversville, New York: Ranbaxy Pharmaceuticals Inc.; 2003. [Accessed 12 Mar. 2019] (online) Available from:
- Gliclazide+Metformin+Voglibose [Product Monograph]. Solan, Himachal Pradesh: Panacea Biotec Limited; 2019. [Accessed 21 Oct. 2021] (online) Available from:
- American Diabetes Association. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S98-S110. [Accessed 21 Oct. 2021] (online) Available from:
Marketer details
Name: Zanjoe Formulation Private Limited
Address: faraz complex , ramesh park Laxmi Nagar , New delhi
Country of origin: India
Lab tests offered by us
Related/Popular tests
MRP
βΉ199
Inclusive of all taxes
10.0 tablet sr in 1 strip
SOLD OUT